Melanie Silverman


Medicaid Plans Need to Prioritize Maternal, Infant Telehealth

As payer and provider organizations look to improve health outcomes around the far-reaching impacts of the pandemic, they must consider the unique needs of some of our most vulnerable populations, such as new and expecting mothers and their infants.

Morris Panner


Enterprise Imaging: A Necessity – Not a Luxury – for Hospitals & Health Systems

Enterprise imaging platforms would enable organizations to consistently and optimally capture, index, manage, store, distribute, view, exchange and analyze all clinical imaging and multimedia content, enhancing patients’ electronic health records.

Denise Myshko


FDA Updates for the Week of March 20, 2023

FDA approvals this week include: novel treatment for invasive candidiasis, an accelerated approval to Zynyz for Merkel cell carcinoma, the high-concentration Humira biosimilar Hyrimoz, and extension of Evkeeza’s indication to include young children. The agency also issued two complete responses this week: for Incyte’s extended-release Jakafi and for AbbVie’s Parkinson’s therapy.

Carolina Nascimento


Digital Transformation is the Revolutionary Change Healthcare Needs

Due to one of the most challenging global crises in living memory and one that presented an acute challenge for the medical community, healthcare providers find themselves operating within an uncertain landscape. They are still managing the fallout of COVID-19 while also planning for the future.

Sobha Pisharody


Precision Medicine vs Trial and Error: Why Pharmacogenomics is Increasingly Relevant

Pharmacogenomics looks at how genetic influences affect an individual’s response to therapeutic medications.

Thomas Foley


Closing the Gap With Virtual Care Services: Reimagining the Delivery of Healthcare

The delivery of care model needs to scale across the community settings while servicing the unique needs of each patient.

Jaime Rosenberg


Drugmakers Look to Quell COVID-19 Cytokine Storms

The FDA rejected Humanigen’s application for an emergency use authorization, but the race is on to develop an effective therapy for the cytokine storms that affect patients with COVID-19.

Nate Allen


Digital Patient Engagement: Helping Uninsured Americans Gain Access to Care

Identifying the right payer before a healthcare service is provided and billing on time, reduces costs, prevents bad debt and maximizes reimbursements and revenue.

Solveig Dittmann


Acute Hospital-at-Home Holds Promise for Hospitals Facing Staffing Shortages

Organizations setting up hospital-at-home programs need to be aware of the associated risks and mitigation best practices.

Janet Walker


Getting Real About Health Equity

CMS and state officials are using payment incentives, data collection and program requirements to start edging the lofty ideals of health equity toward reality.

Angie Meoli


Collaborating to Support Better Outcomes Through Value-Based Care

Engaging with payers in collaborative arrangements is critical for achieving quality outcomes at lower cost, while ensuring financial health for providers during good times and bad.

Jonathan E. Levitt


Why Timing Matters When It Comes to PBM Contracting

Plan sponsors should begin evaluation of PBM performance at least a year before the contract expires, say lawyers with expertise in PBM contracting.

Adam Sabloff


Health Plans Are Managing More Data Than Ever Before. How to Ensure It’s Usable.

Health plans need to consider regulations and keep healthcare data secure to take full advantage of its enormous potential to broaden and reshape timely, effective delivery of care.

Sebastian Seiguer


The Future of the Growing Medication Adherence Market

Patients with chronic conditions like asthma, diabetes, and cardiovascular disease often require emergency attention and hospitalization due to non-adherence, resulting in higher treatment costs.

Joan Kapusnik-Uner, Pharm.D., FCSHP, FASHP


Clinical Decision Support Can Help Identify Common Drugs Linked with Increased Arrhythmia and Sudden Death Risk

Research has linked many drugs to QT prolongation and decision support tools could alert clinicians to the risk and guide prescribing decisions to safer alternatives.

Akhilesh Ayer


Pharma: Striding Towards the Digital-only Reality with AI

As industries across the board move towards a digital-only world, pharma companies must account for the different technologies that are transforming the R&D process.

Dae Y. Lee


Why Timing Matters When It Comes to PBM Contracting

Plan sponsors should begin evaluation of PBM performance at least a year before the contract expires, say lawyers with expertise in PBM contracting.

Ian E. Krop, MD, PhD


Value-Based Decision-Making in Metastatic Breast Cancer

In this Managed Healthcare Executive® KCast, Ian Krop, M.D., Ph.D., oncologist and associate professor of medicine at Dana-Farber Cancer Institute in Boston, and Debra Patt, M.D., Ph.D., MBA, executive vice president at Texas Oncology in Austin, provide key insights into the value-based care model for patients with HER2-positive metastatic breast cancer (mBC). This article summarizes the highlights of the discussion.

Paul Boal


How to Recognize, Capitalize on the Benefits of Price Transparency in Healthcare

Hospital leaders who have historically viewed price transparency as potentially disastrous can tap into these three tips to leave that mindset behind and capitalize on the opportunities that price transparency provides.

Michael Pattwell


Accelerating Value-Based Care Transformation Today and Post COVID-19

One year into the COVID-19 pandemic and healthcare leaders are taking a hard look at all operations – especially innovative reimbursement models that best meet the needs of their business, providers and patients. No doubt these leaders are finally paying closer attention to value-based care.

John Schwartz


Exploring the Critical First Step in Adding and Paying CBOs in Value-based Contracts

The transition from treating patients at a provider’s site to delivering care in the home and community requires two things: an ability to incorporate social determinants of health into the care coordination process and the inclusion of value-based care and community-based organizations as compensated care delivery partners in VBC networks.

Ankur Parikh, M.D.


COVID-19 Has Changed Cancer Care — For the Better

The pandemic has led to the adoption of telehealth and greater access to care through apps.

Ryan Bitton, PharmD, MBA


Long-Acting Injectable PrEP Therapy for HIV

Types of patients who will likely benefit from long-acting injectable PrEP therapies in the HIV treatment pipeline.

Theresa Hush, CEO and co-founder, Roji Healthcare Intelligence


How to Avoid Squandering Data Resources for APP Reporting

Does your transition to Alternate Payment Model Performance Pathways (APP) quality reporting have your ACO scrambling for data? No surprise.

Spencer Draper


The Hospital Room: Preventing Nurse Burnout with In-Room Technology

This opinion piece contributed by Draper voices today's digital platforms can help eliminate the administrative burden on nurses.

Charlie Lougheed


Combatting the Clinician Shortage Through Robotic Process Automation

As the clinician shortage continues, leaning on technology to streamline inefficiencies is essential.

Suman Giri, Ph.D., and Shitang Patel


Supercharge Your Star Rating Improvement Efforts Using Machine Learning

Optimizing your Star Rating program with machine learning technology.

© 2023 MJH Life Sciences

All rights reserved.